Insurers Get Goldman Downgrade

NEW YORK ( TheStreet) -- Property and Casualty insurer valuations are "broadly appropriate" for the sector, according to Goldman Sachs analysts, who lowered their sector recommendation to "Neutral" from "Attractive" in a note published Tuesday.

The analysts, led by Michael Nanizzi, note that the sector trades at book value and they estimate it will post a 10% return on equity (ROE) in 2013.

"Given that our baseline for valuation is roughly 10 times forward ROE, the group seems fairly valued at this point," the report states.

In downgrading the sector, Goldman dropped RenaissanceRe ( RNR) to "Neutral" from "Attractive," while lowering W.R. Berkley ( WRB) to "Sell" from "Neutral." The analysts reiterated their buy rating on Travelers ( TRV), but removed the company from the "Conviction Buy" list.

Goldman's analysts haven't grown more bearish on all the P&C insurers. They upgraded XL Group ( XL) to "Neutral" from "Sell," and they continue to recommend AIG ( AIG) and Everest Re Group ( RE). Validus Holdings ( VR), meanwhile, remains a "conviction" buy.

Regarding AIG, the analysts argue "aggressive pricing and underwriting actions" at its Chartis P&C division "will lift trough earnings and support an increasing focus on fundamental valuation." The recommendations of Validus and Everest Re are largely due to their still-low valuations.

-- Written by Dan Freed in New York.

Disclosure: TheStreet's editorial policy prohibits staff editors, reporters and analysts from holding positions in any individual stocks.

More from Stocks

General Electric's Boot From the Dow: Is This as Bad as It Can Get?

General Electric's Boot From the Dow: Is This as Bad as It Can Get?

News From Starbucks and General Electric Leaves Their Investors Up in Arms

News From Starbucks and General Electric Leaves Their Investors Up in Arms

Facebook Messenger Could Bring in Billions of Dollars -- Here's How

Facebook Messenger Could Bring in Billions of Dollars -- Here's How

How to Invest in Cannabis - In Its Many Forms

How to Invest in Cannabis - In Its Many Forms

5 Stocks That Are Screaming Buys Right Now

5 Stocks That Are Screaming Buys Right Now